- Home
- BCML vs ALDX Comparison
BCML vs ALDX Comparison
Compare BCML & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCML | ALDX |
|---|---|---|
| Founded | 2004 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.2M | 317.7M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BCML | ALDX |
|---|---|---|
| Price | $29.77 | $1.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $34.00 | $5.50 |
| AVG Volume (30 Days) | 17.0K | ★ 5.7M |
| Earning Date | 04-23-2026 | 05-13-2026 |
| Dividend Yield | ★ 4.05% | N/A |
| EPS Growth | 3.81 | ★ 40.43 |
| EPS | ★ 2.18 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.71 | N/A |
| Revenue Next Year | $5.25 | $9.72 |
| P/E Ratio | $13.58 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.22 | $1.07 |
| 52 Week High | $33.15 | $6.18 |
Technical Indicators
Market Signals| Indicator | BCML | ALDX |
|---|---|---|
| Relative Strength Index (RSI) | 55.90 | 28.36 |
| Support Level | $29.17 | $1.07 |
| Resistance Level | $30.61 | $5.75 |
| Average True Range (ATR) | 0.74 | 0.28 |
| MACD | 0.12 | -0.03 |
| Stochastic Oscillator | 76.59 | 17.60 |
Price Performance
Historical ComparisonAbout BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.